Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

CKD: A Call for an Age-Adapted Definition.

Delanaye P, Jager KJ, Bökenkamp A, Christensson A, Dubourg L, Eriksen BO, Gaillard F, Gambaro G, van der Giet M, Glassock RJ, Indridason OS, van Londen M, Mariat C, Melsom T, Moranne O, Nordin G, Palsson R, Pottel H, Rule AD, Schaeffner E, Taal MW, White C, Grubb A, van den Brand JAJG.

J Am Soc Nephrol. 2019 Sep 10. pii: ASN.2019030238. doi: 10.1681/ASN.2019030238. [Epub ahead of print] Review.

PMID:
31506289
2.

Predicting kidney failure from longitudinal kidney function trajectory: A comparison of models.

van den Brand JAJG, Dijkstra TMH, Wetzels J, Stengel B, Metzger M, Blankestijn PJ, Lambers Heerspink HJ, Gansevoort RT.

PLoS One. 2019 May 9;14(5):e0216559. doi: 10.1371/journal.pone.0216559. eCollection 2019.

3.

Performance of creatinine-based equations for estimating glomerular filtration rate changes over time.

van Rijn MHC, Metzger M, Flamant M, Houillier P, Haymann JP, van den Brand JAJG, Froissart M, Stengel B; NephroTest Study Group.

Nephrol Dial Transplant. 2018 Sep 1. doi: 10.1093/ndt/gfy278. [Epub ahead of print]

PMID:
30184233
4.

Graft intolerance syndrome requiring graft nephrectomy after late kidney graft failure: can it be predicted? A retrospective cohort study.

Bunthof KLW, Verhoeks CM, van den Brand JAJG, Hilbrands LB.

Transpl Int. 2018 Feb;31(2):220-229. doi: 10.1111/tri.13088. Epub 2017 Nov 16.

5.

Causality on longitudinal data: Stable specification search in constrained structural equation modeling.

Rahmadi R, Groot P, van Rijn MH, van den Brand JA, Heins M, Knoop H, Heskes T; Alzheimer’s Disease Neuroimaging Initiative; MASTERPLAN Study Group; OPTIMISTIC consortium.

Stat Methods Med Res. 2018 Dec;27(12):3814-3834. doi: 10.1177/0962280217713347. Epub 2017 Jun 28.

6.

Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.

van den Brand JAJG, Ruggenenti P, Chianca A, Hofstra JM, Perna A, Ruggiero B, Wetzels JFM, Remuzzi G.

J Am Soc Nephrol. 2017 Sep;28(9):2729-2737. doi: 10.1681/ASN.2016091022. Epub 2017 May 9.

7.

Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome.

van den Brand JA, Verhave JC, Adang EM, Wetzels JF.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i115-i122. doi: 10.1093/ndt/gfw353.

PMID:
28391343
8.

Statistical significance versus clinical relevance.

van Rijn MHC, Bech A, Bouyer J, van den Brand JAJG.

Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii6-ii12. doi: 10.1093/ndt/gfw385.

PMID:
28064161
9.

Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.

Zittema D, van den Brand JA, Bakker SJ, Wetzels JF, Gansevoort RT.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i146-i153. doi: 10.1093/ndt/gfw391.

PMID:
28057871
10.

Uremic Solutes in Chronic Kidney Disease and Their Role in Progression.

van den Brand JA, Mutsaers HA, van Zuilen AD, Blankestijn PJ, van den Broek PH, Russel FG, Masereeuw R, Wetzels JF.

PLoS One. 2016 Dec 29;11(12):e0168117. doi: 10.1371/journal.pone.0168117. eCollection 2016.

11.

Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry.

van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ.

Nephrol Dial Transplant. 2017 Feb 1;32(2):348-355. doi: 10.1093/ndt/gfw392.

PMID:
28031344
12.

Diabetes mellitus as a cause of end-stage renal disease in Europe: signs of improvement.

van den Brand JA.

Clin Kidney J. 2016 Jun;9(3):454-6. doi: 10.1093/ckj/sfw029. Epub 2016 May 24. No abstract available.

13.

Abdominal aortic calcification in patients with CKD.

Peeters MJ, van den Brand JA, van Zuilen AD, Koster Y, Bots ML, Vervloet MG, Blankestijn PJ, Wetzels JF; MASTERPLAN Study Group.

J Nephrol. 2017 Feb;30(1):109-118. doi: 10.1007/s40620-015-0260-7. Epub 2016 Mar 22.

14.

Immunosuppressive therapy in patients with IgA nephropathy.

Peters HP, van den Brand JA, Berger SP, Wetzels JF.

Neth J Med. 2015 Jul;73(6):284-9.

15.

Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.

Mutsaers HA, Caetano-Pinto P, Seegers AE, Dankers AC, van den Broek PH, Wetzels JF, van den Brand JA, van den Heuvel LP, Hoenderop JG, Wilmer MJ, Masereeuw R.

Toxicol In Vitro. 2015 Oct;29(7):1868-77. doi: 10.1016/j.tiv.2015.07.020. Epub 2015 Jul 26.

PMID:
26216510
16.

Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.

Maas RJ, van den Brand JA, Waanders F, Meijer E, Goor van H, Peters HP, Hofstra JM, Wetzels JF.

Ann Clin Biochem. 2016 Jan;53(Pt 1):51-7. doi: 10.1177/0004563215579694. Epub 2015 Mar 11.

PMID:
25762211
17.

Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.

Bech AP, Bouma-de Krijger A, van Zuilen AD, Bots ML, van den Brand JA, Blankestijn PJ, Wetzels JF, Vervloet MG.

J Nephrol. 2015 Aug;28(4):477-84. doi: 10.1007/s40620-015-0178-0. Epub 2015 Feb 21.

18.

Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy.

van den Brand JA, van Dijk PR, Hofstra JM, Wetzels JF.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1066-73. doi: 10.2215/CJN.08880813. Epub 2014 May 22.

19.

Nurse practitioner care improves renal outcome in patients with CKD.

Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Blankestijn PJ, Wetzels JF.

J Am Soc Nephrol. 2014 Feb;25(2):390-8. doi: 10.1681/ASN.2012121222. Epub 2013 Oct 24.

20.

Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy.

van den Brand JA, van Dijk PR, Hofstra JM, Wetzels JF.

J Am Soc Nephrol. 2014 Jan;25(1):150-8. doi: 10.1681/ASN.2013020185. Epub 2013 Sep 12.

21.

Validation of the kidney failure risk equation in European CKD patients.

Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, Blankestijn PJ, Wetzels JF; MASTERPLAN Study Group.

Nephrol Dial Transplant. 2013 Jul;28(7):1773-9. doi: 10.1093/ndt/gft063. Epub 2013 May 3.

PMID:
23645476
22.

A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation.

Maas RJ, Deegens JK, van den Brand JA, Cornelissen EA, Wetzels JF.

BMC Nephrol. 2013 Feb 22;14:47. doi: 10.1186/1471-2369-14-47.

23.

Differences between hospitals in attainment of parathyroid hormone treatment targets in chronic kidney disease do not reflect differences in quality of care.

Peeters MJ, van Zuilen AD, van den Brand JA, Blankestijn PJ, ten Dam MA, Wetzels JF.

BMC Nephrol. 2012 Aug 6;13:82. doi: 10.1186/1471-2369-13-82.

24.

Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA.

Peters HP, Rumjon A, Bansal SS, Laarakkers CM, van den Brand JA, Sarafidis P, Musto R, Malyszko J, Swinkels DW, Wetzels JF, Macdougall IC.

Nephrol Dial Transplant. 2012 Oct;27(10):3923-9. doi: 10.1093/ndt/gfs164. Epub 2012 Jul 19.

PMID:
22815544
25.

Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.

van den Brand JA, Hofstra JM, Wetzels JF.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1242-8. doi: 10.2215/CJN.00670112. Epub 2012 May 17.

26.

Epidemiology of contrast material-induced nephropathy in the era of hydration.

Balemans CE, Reichert LJ, van Schelven BI, van den Brand JA, Wetzels JF.

Radiology. 2012 Jun;263(3):706-13. doi: 10.1148/radiol.12111667. Epub 2012 Apr 24.

PMID:
22535561
27.

Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy.

van den Brand JA, Hofstra JM, Wetzels JF.

Clin J Am Soc Nephrol. 2011 Dec;6(12):2846-53. doi: 10.2215/CJN.04020411.

28.

Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes.

Haring CM, Rietveld A, van den Brand JA, Berden JH.

J Am Soc Nephrol. 2012 Jan;23(1):149-54. doi: 10.1681/ASN.2011060558. Epub 2011 Oct 27.

29.

Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population.

van den Brand JA, van Boekel GA, Willems HL, Kiemeney LA, den Heijer M, Wetzels JF.

Nephrol Dial Transplant. 2011 Oct;26(10):3176-81. doi: 10.1093/ndt/gfr003. Epub 2011 Feb 16.

PMID:
21325352
30.

Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.

Peters HP, van den Brand JA, Wetzels JF.

Neth J Med. 2009 Feb;67(2):54-61.

31.

The influence of the method of preparation of the bone scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat.

Van den Brand JA, Das HA, Dekker BG, de Ligny CL, Van den Hamer CJ.

Int J Appl Radiat Isot. 1982 Oct;33(10):917-28.

PMID:
6818161
32.

The influence of experimental conditions on the formation of various 99mTc(Sn)EHDP complexes.

van den Brand JA, Das HA, Dekker BG, de Ligny L.

Int J Appl Radiat Isot. 1982 Jan;33(1):39-45. No abstract available.

PMID:
6800964

Supplemental Content

Loading ...
Support Center